Article Details
Retrieved on: 2024-07-16 19:02:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Directors, entered a license agreement with Pluristyx and received Regenerative Medicine Advanced Therapy (RMAT) designation by the FDA for its A…
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here